These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21593735)

  • 1. Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility.
    Dobrinas M; Cornuz J; Oneda B; Kohler Serra M; Puhl M; Eap CB
    Clin Pharmacol Ther; 2011 Jul; 90(1):117-25. PubMed ID: 21593735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking.
    Dobrinas M; Cornuz J; Pedrido L; Eap CB
    Pharmacogenet Genomics; 2012 Feb; 22(2):143-51. PubMed ID: 22246422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population.
    Gunes A; Ozbey G; Vural EH; Uluoglu C; Scordo MG; Zengil H; Dahl ML
    Pharmacogenomics; 2009 May; 10(5):769-78. PubMed ID: 19450128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers.
    Pavanello S; Pulliero A; Lupi S; Gregorio P; Clonfero E
    Mutat Res; 2005 Nov; 587(1-2):59-66. PubMed ID: 16188490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers.
    Dobrinas M; Cornuz J; Eap CB
    Pharmacogenet Genomics; 2013 May; 23(5):286-92. PubMed ID: 23492909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytochrome P4501A2.
    Landi MT; Sinha R; Lang NP; Kadlubar FF
    IARC Sci Publ; 1999; (148):173-95. PubMed ID: 10493258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotypes in the 5'-untranslated region of the CYP1A2 gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism.
    Gervasini G; Ghotbi R; Aklillu E; San Jose C; Cabanillas A; Kishikawa J; Benitez J; Carrillo JA
    Environ Mol Mutagen; 2013 Mar; 54(2):124-32. PubMed ID: 23138776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
    Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
    Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.
    Aklillu E; Carrillo JA; Makonnen E; Hellman K; Pitarque M; Bertilsson L; Ingelman-Sundberg M
    Mol Pharmacol; 2003 Sep; 64(3):659-69. PubMed ID: 12920202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS; Fuhr U
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis.
    Koonrungsesomboon N; Khatsri R; Wongchompoo P; Teekachunhatean S
    Pharmacogenomics J; 2018 Dec; 18(6):760-768. PubMed ID: 29282363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans.
    Ghotbi R; Christensen M; Roh HK; Ingelman-Sundberg M; Aklillu E; Bertilsson L
    Eur J Clin Pharmacol; 2007 Jun; 63(6):537-46. PubMed ID: 17370067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
    Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
    Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2.
    Han XM; Ouyang DS; Chen XP; Shu Y; Jiang CH; Tan ZR; Zhou HH
    Br J Clin Pharmacol; 2002 Nov; 54(5):540-3. PubMed ID: 12445035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
    Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
    Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
    Takata K; Saruwatari J; Nakada N; Nakagawa M; Fukuda K; Tanaka F; Takenaka S; Mihara S; Marubayashi T; Nakagawa K
    Eur J Clin Pharmacol; 2006 Jan; 62(1):23-8. PubMed ID: 16385402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
    Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
    Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
    Nakajima M; Yokoi T; Mizutani M; Shin S; Kadlubar FF; Kamataki T
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):413-21. PubMed ID: 7920209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
    Bondolfi G; Morel F; Crettol S; Rachid F; Baumann P; Eap CB
    Ther Drug Monit; 2005 Aug; 27(4):539-43. PubMed ID: 16044115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.